Rich Insights into the Heart Failure Clinical Trial Analysis Featuring 75+ Companies and Therapies | DelveInsight

Source :: PR Newswire. April 4, 2023
Publication Year :: 2023
Abstract: Currently, much research is ongoing to develop new and effective therapeutic drugs for the treatment of Heart failure. The treatment of HF is dependent on angiotensin-converting enzyme inhibitor, angiotensin receptor [...]

Subjects :: Bristol-Myers Squibb Co. -- Forecasts and trends
Rivaroxaban -- Forecasts and trends
Business -- Research
Enzyme inhibitors -- Forecasts and trends
Clinical trials -- Forecasts and trends
Pharmaceutical industry -- Forecasts and trends
Angiotensin -- Forecasts and trends
Diuretics -- Forecasts and trends
Heart failure -- Forecasts and trends
Market trend/market analysis
Business
News, opinion and commentary

Tools